Humana Inc. today announced research findings that suggest inferior vena cava (IVC) filters may be overused in managed care populations, and that filters may not always be removed after they are no ...

New York, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "EU5 Clot Management Procedures Outlook to 2025 - Inferior Vena Cava Filters (IVCF) Procedures and ...

SILVER SPRING, Md., Dec. 21, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration authorized marketing of the first laser-based device for the removal of Inferior Vena Cava (IVC) filters.

Designed to temporarily prevent blood clots from traveling to the lungs, approximately 85% of inferior vena cava filters inserted over an eight-year period were not removed, according to a study ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Dear Dr. Roach • In November 1997, while traveling, I had a pulmonary embolism. I was treated with urokinase to the lungs and a ...

Inferior vena cava filters are supposed to save lives. The spider-like devices catch blood clots before they can travel up to the lung and cause deadly pulmonary embolisms. But for over a decade, ...

Philips has scored a de novo clearance from the FDA for the first laser-based device for removing blood vessel filter implants that aim to strain out traveling blood clots before they damage the lungs ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window FDA approved the ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced it has authorized marketing of the first laser-based device for the removal of inferior vena ...

The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...